Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.55 |
| ▸ | HTR2A | P28223 | 2/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8770696 | 1.00 | HTR6 (0.55) | HTR6HTR2ASIGMAR1KDM4ECYP2D6 | |
| SCHEMBL668105 | 0.98 | HTR6 (0.56) | HTR6HTR2ASIGMAR1KDM4ECYP2D6 | |
| SCHEMBL9860070 | 0.95 | HTR6 (0.55) | HTR6HTR2ASIGMAR1KDM4ECYP2D6 | |
| SCHEMBL9144867 | 0.95 | HTR6 (0.55) | HTR6HTR2ASIGMAR1KDM4ECYP2D6 | |
| SCHEMBL5604259 | 0.95 | HTR6 (0.55) | HTR6HTR2ASIGMAR1KDM4ECYP2D6 | |
| SCHEMBL20952390 | 0.95 | HTR6 (0.55) | HTR6HTR2ASIGMAR1KDM4ECYP2D6 | |
| Hydrochloric Acid SCHEMBL29672904 | 0.93 | HTR6 (0.53) | HTR6HTR2ASIGMAR1KDM4ECYP2D6 | |
| Hydrochloric Acid SCHEMBL7699824 | 0.93 | HTR6 (0.53) | HTR6HTR2ASIGMAR1KDM4ECYP2D6 | |
| Methylamine SCHEMBL28004018 | 0.91 | HTR6 (0.56) | HTR6HTR2ASIGMAR1KDM4ECYP2D6 | |
| SCHEMBL20211959 | 0.90 | HTR6 (0.50) | HTR6HTR2ASIGMAR1KDM4ECYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7619106-B2 | Preparation of partially hydrogenated rac-ansa-metallocene complexes | BASELL POLYOLEFINE GMBH (DE) | 2009-11-17 | — | — | US | claimed |
| US-20080200708-A1 | Preparation of Partially Hydrogenated Rac-Ansa-Metallocene Complexes | BASELL POLYOLEFINE GMBH (DE) | 2008-08-21 | — | — | US | claimed |
| EP-1554295-B1 | PREPARATION OF PARTIALLY HYDROGENATED RAC-ANSA-METALLOCENE COMPLEXES | BASELL POLYOLEFINE GMBH (DE) | 2008-07-02 | — | — | EP | claimed |
| EP-1554295-A1 | PREPARATION OF PARTIALLY HYDROGENATED RAC-ANSA-METALLOCENE COMPLEXES | Basell Polyolefine GmbH (DE) | 2005-07-20 | — | — | EP | claimed |
| WO-2004037838-A1 | PREPARATION OF PARTIALLY HYDROGENATED RAC-ANSA-METALLOCENE COMPLEXES | BASELL POLYOLEFINE GMBH (DE) | 2004-05-06 | — | — | WO | claimed |
| US-7619106-B2 | Preparation of partially hydrogenated rac-ansa-metallocene complexes | BASELL POLYOLEFINE GMBH (DE) | 2009-11-17 | — | — | US | disclosed |
| EP-1556417-B1 | RACEMOSELECTIVE PREPARATION OF BRIDGED METALLOCENE COMPLEXES HAVING UNSUBSTITUTED OR 2-SUBSTITUTED INDENYL LIGANDS | BASELL POLYOLEFINE GMBH (DE) | 2009-06-10 | — | — | EP | disclosed |
| US-20080200708-A1 | Preparation of Partially Hydrogenated Rac-Ansa-Metallocene Complexes | BASELL POLYOLEFINE GMBH (DE) | 2008-08-21 | — | — | US | disclosed |
| EP-1554295-B1 | PREPARATION OF PARTIALLY HYDROGENATED RAC-ANSA-METALLOCENE COMPLEXES | BASELL POLYOLEFINE GMBH (DE) | 2008-07-02 | — | — | EP | disclosed |
| US-7160949-B2 | Olefin block copolymers, processes for producing the same and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2007-01-09 | — | — | US | disclosed |
| EP-1275670-B1 | OLEFIN BLOCK COPOLYMERS, PRODUCTION PROCESSES OF THE SAME AND USE THEREOF | MITSUI CHEMICALS INC (JP) | 2005-08-10 | — | — | EP | disclosed |
| EP-1554295-A1 | PREPARATION OF PARTIALLY HYDROGENATED RAC-ANSA-METALLOCENE COMPLEXES | Basell Polyolefine GmbH (DE) | 2005-07-20 | — | — | EP | disclosed |
| WO-2004037838-A1 | PREPARATION OF PARTIALLY HYDROGENATED RAC-ANSA-METALLOCENE COMPLEXES | BASELL POLYOLEFINE GMBH (DE) | 2004-05-06 | — | — | WO | disclosed |
| US-20030055179-A1 | Olefin block copolymers processes for producing the same and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2003-03-20 | — | — | US | disclosed |
| EP-1275670-A1 | OLEFIN BLOCK COPOLYMERS, PRODUCTION PROCESSES OF THE SAME AND USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2003-01-15 | — | — | EP | disclosed |
| EP-0452920-B1 | Process for the preparation of an ethylene copolymer and an olefin polymer, and catalysts for olefin polymerization | MITSUI CHEMICALS INC (JP) | 2001-10-10 | — | — | EP | disclosed |
| US-5883205-A | ETHYLENE POLYMERIZATION IN SUSPENSION OR VAPOR PHASE WITH CATALYST OF CYCLOPENTADIENE, TRANSITION METAL, ORGANOALUMINUM OXY COMPOUND | MITSUI CHEMICALS, INC. (JP) | 1999-03-16 | — | — | US | disclosed |
| US-5840815-A | POLYMERIZING OLEFIN IN PRESENCE OF SOLID CATALYST FORMED FROM COMPOUND OF GROUP IVB METAL HAVING CYCLOPENTADIENE-BASED LIGANDS, ORGANOALUMINUM OXY-COMPOUND | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1998-11-24 | — | — | US | disclosed |
| EP-0462588-A2 | Olefin block copolymer and method of producing same | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1991-12-27 | — | — | EP | disclosed |
| EP-0452920-A2 | Process for the preparation of an ethylene copolymer and an olefin polymer, and catalysts for olefin polymerization | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200708-A1 | Preparation of Partially Hydrogenated Rac-Ansa-Metallocene Complexes | HRAS, RAP1A, NBAS | HTR6 2018/4885HTR2A 1313/4885SIGMAR1 1030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.